Close
New

Medscape is available in 4 Language Editions – Choose your Edition here.

Wednesday, March 23, 2016
close

Top Medical News from Across Medscape

  • Botox Alleviates Neuropathic PainA series of two doses of botulinum toxin A relieved neuropathic pain better than did placebo, new randomized findings show.
  • Medical Marijuana Advocates Rally to Loosen RestrictionsMedical marijuana advocates are hoping Congress will approve reclassification of the drug from schedule I to schedule II, but legislation to do that has not gained much traction on Capitol Hill.
  • New FDA Safety Warnings on Immediate-Release OpioidsThe agency has added a new boxed warning about the risks for misuse, abuse, addiction, overdose, and death and changes the indication to treatment of severe pain with no alternatives.
  • Subjective Memory Complaints: Trouble AheadEvidence is mounting that patients' complaints of memory loss are indeed strong indicators of future cognitive impairment and should be addressed.

Special Report

  • The news about Zika is rapidly changing.  Our resource center provides the most recent developments along with the implications for clinicians in the US and abroad.

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.